Literature DB >> 3260604

Demonstration of reduced mitogenic and osteoinductive activities in demineralized allogeneic bone matrix from vitamin D-deficient rats.

R T Turner1, J Farley, J J Vandersteenhoven, S Epstein, N H Bell, D J Baylink.   

Abstract

Osteoinduction is the formation of ectopic bone that follows implantation of demineralized allogeneic bone matrix (DABM) and is believed to be secondary to the release of associated inductive factors from bone matrix. To clarify the role of vitamin D in osteoinduction, we implanted DABM from vitamin D-deficient rats (-D rats) into normal rats (+D rats). Because mitogens and osteocalcin might be involved in osteoinduction, these were measured. Mitogenic activity in extracts from mineralized allogeneic bone matrix (ABM) and DABM from both +D and -D rats was determined with an assay that utilizes monolayer cultures of embryonic chick calvarial cells. Osteocalcin in serum and DABM was measured by radioimmunoassay. DABM from -D rats did not promote osteoinduction as effectively as DABM from +D rats. Resorption of implant matrix from -D rats was diminished compared with resorption of matrix from +D rats (P less than 0.01), and the decrease was attributed to a corresponding decrease in the number of osteoclasts in the implants (P less than 0.02). Bone formation (P less than 0.01) and total implant mineralization (P less than 0.001) were significantly reduced in implants from -D rats, and the reductions corresponded with a decline in the number of osteoblasts (P less than 0.05). Mitogenic activity in DABM from +D rats was only slightly decreased as compared with activity in ABM, but DABM from -D rats contained significantly less activity (P less than 0.001). No mitogenic activity was identified in implants of DABM from either +D or -D rats 3 wk after implantation. Serum osteocalcin was significantly higher in -D as compared with +D animals. In contrast, the concentrations of osteocalcin in DABM from the two groups of animals were not significantly different from each other. These findings indicate that the diminished osteoinductive activity of DABM from -D rats results from deficiency of one or more mitogenic factors that are essential for inducing the proliferation and differentiation of bone cells at the implant site and that osteocalcin does not play a role in this regard.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3260604      PMCID: PMC303496          DOI: 10.1172/JCI113573

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  32 in total

1.  Formation of bone marrow in fibroblast-transformation ossicles.

Authors:  A H Reddi; C B Huggins
Journal:  Proc Natl Acad Sci U S A       Date:  1975-06       Impact factor: 11.205

2.  Bone matrix studies. Influences of parathyroid extract, calcitonin, and cholecalciferol and of rickets and its treatment.

Authors:  W P Deiss; D L Hern
Journal:  Biochim Biophys Acta       Date:  1979-05-01

3.  Collagen heterogeneity within different growth regions of long bones of rachitic and non-rachitic chicks.

Authors:  B P Toole; A H Kang; R L Trelstad; J Gross
Journal:  Biochem J       Date:  1972-05       Impact factor: 3.857

4.  Bone: formation by autoinduction.

Authors:  M R Urist
Journal:  Science       Date:  1965-11-12       Impact factor: 47.728

5.  Effect of growth hormone on osteoblasts and demonstration of somatomedin-C/IGF I in bone organ culture.

Authors:  H Stracke; A Schulz; D Moeller; S Rossol; H Schatz
Journal:  Acta Endocrinol (Copenh)       Date:  1984-09

6.  1,25-dihydroxyvitamin D3 increases serum levels of the vitamin K-dependent bone protein.

Authors:  P A Price; S A Baukol
Journal:  Biochem Biophys Res Commun       Date:  1981-04-15       Impact factor: 3.575

7.  Human skeletal growth factor: characterization of the mitogenic effect on bone cells in vitro.

Authors:  J R Farley; T Masuda; J E Wergedal; D J Baylink
Journal:  Biochemistry       Date:  1982-07-06       Impact factor: 3.162

8.  Bone collagen metabolism in vitamin D deficiency.

Authors:  M J Barnes; B J Constable; L F Morton; E Kodicek
Journal:  Biochem J       Date:  1973-01       Impact factor: 3.857

9.  Chemotactic activity of the gamma-carboxyglutamic acid containing protein in bone.

Authors:  G R Mundy; J W Poser
Journal:  Calcif Tissue Int       Date:  1983       Impact factor: 4.333

10.  Bone and serum concentrations of osteocalcin as a function of 1,25-dihydroxyvitamin D3 circulating levels in bone disorders in rats.

Authors:  J B Lian; D L Carnes; M J Glimcher
Journal:  Endocrinology       Date:  1987-05       Impact factor: 4.736

View more
  3 in total

1.  Vitamin D deficiency causes a selective reduction in deposition of transforming growth factor beta in rat bone: possible mechanism for impaired osteoinduction.

Authors:  R D Finkelman; T A Linkhart; S Mohan; K H Lau; D J Baylink; N H Bell
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

2.  Equilibrium-dependent bisphosphonate interaction with crystalline bone mineral explains anti-resorptive pharmacokinetics and prevalence of osteonecrosis of the jaw in rats.

Authors:  Akishige Hokugo; Shuting Sun; Sil Park; Charles E McKenna; Ichiro Nishimura
Journal:  Bone       Date:  2012-12-04       Impact factor: 4.398

3.  Ovariectomy selectively reduces the concentration of transforming growth factor beta in rat bone: implications for estrogen deficiency-associated bone loss.

Authors:  R D Finkelman; N H Bell; D D Strong; L M Demers; D J Baylink
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.